Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Amphetamine-related disorders (1)
- Arrhythmia (1)
- Atomoxetine (1)
- Cardiac (1)
- Cardiomyopathies (1)
-
- Critical care (1)
- Methamphetamine abuse (1)
- Methamphetamine cardiomyopathy (1)
- Methamphetamine/adverse effects (1)
- Metilphenidate (1)
- Obstetrics (1)
- Peripartum cardiomyopathy (1)
- Pregnancy complications (1)
- Reversible cardiomyopathy (1)
- Stimulants (1)
- Stress induced cardiomyopathy (1)
- Substance-related disorders (1)
- Takotsubo cardiomyopathy (1)
Articles 1 - 2 of 2
Full-Text Articles in Cardiology
Mental Health Or Cardiac Health. Is There A Reason To Choose? Cardiac Arrhythmias Induced By Atomoxetine And Methylphenidate, Gabriel Cismaru, Viorel Lupu
Mental Health Or Cardiac Health. Is There A Reason To Choose? Cardiac Arrhythmias Induced By Atomoxetine And Methylphenidate, Gabriel Cismaru, Viorel Lupu
Journal of Mind and Medical Sciences
The current treatment of Attention Deficit Disorder and Attention Deficit with Hyperactivity consists mainly in the administration of Straterra (Atomoxetine) Concerta and Ritalin (Methylphenidate). The FDA warned that the products might increase systolic, diastolic blood pressure, and lead to ventricular arrhythmias. Arrhythmic events and sudden cardiac death were described in adults with preexistent heart disease. However, studies on children have failed to demonstrate a clear association between the arrhythmic events and these drugs, as demonstrated in adults. What should the attitude of the pediatric psychiatrist be towards the administration of these products? What examination should be made by the psychiatrist …
Methamphetamine Associated Cardiomyopathy In Pregnancy: The Distinctions And The Implications, Ashan Hatharasinghe, Hossein Akhondi
Methamphetamine Associated Cardiomyopathy In Pregnancy: The Distinctions And The Implications, Ashan Hatharasinghe, Hossein Akhondi
HCA Healthcare Journal of Medicine
Introduction
Methamphetamine associated cardiomyopathy (MAC) and peripartum cardiomyopathy (PPCM) are both rare obstetric conditions. Literature regarding methamphetamine associated cardiomyopathy in the obstetric population is limited, and it can be difficult to make the distinction between the two given the similarities in clinical presentation. However similar, there are significant distinctions in the pathophysiology of these two that can help clinicians with the management process.
Clinical Findings and Outcomes
This case involves a 35-year-old Hispanic G6P5005 at 37 weeks gestation presenting with acute respiratory failure secondary to acute decompensated heart failure with reduced ejection fraction and superimposed preeclampsia leading to urgent cesarean …